Potent Lys Patch-Containing Stapled Peptides Targeting PCSK9
Author:
Affiliation:
1. IBMM, ENSCM, Université de Montpellier, CNRS, 34093 Montpellier, France
2. Sanofi Aventis R&D, 1 Avenue Pierre Brossolette, 91380 Chilly-Mazarin, France
3. Sanofi, 153 2nd Avenue, Waltham, Massachusetts 02451, United States
Funder
Sanofi
Association Nationale de la Recherche et de la Technologie
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c02051
Reference66 articles.
1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2. A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
4. Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
5. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives;Amino Acids;2024-05-31
2. New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery;The Handbook of Medicinal Chemistry;2023-02-03
3. Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment;Journal of Medicinal Chemistry;2022-11-29
4. Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors;Journal of Medicinal Chemistry;2022-10-14
5. Improving Stability Enhances In Vivo Efficacy of a PCSK9 Inhibitory Peptide;Journal of the American Chemical Society;2022-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3